Address:
810, ch. du Golf
Verdun, QC H3E 1A8
CA
Mailling Address:
810, ch. du Golf
Verdun, QC H3E 1A8
CA
Phone:
(514) 288-5532
Fax:
(514) 288-9280
Email:
Click Here
Map it:
Click Here
Website:
http://www.aegera.com
Aegera Therapeutics Inc.
Aegera Therapeutics Inc. is a private North American
biotechnology company focused on exploiting apoptosis control to
extend and enhance life: killing cancer cells by inducing
apoptosis and protecting nerve cells from chemotherapy-induced
death. Aegeras lead oncology program is a XIAP antisense
herapeutic which will enter the clinic in Q1 2004. A second
oncology program, the AEG3482 Small Molecule Series, is
scheduled to enter clinical trials in late 2004, to treat
hemotherapy-induced neuropathy, the largest remaining untreated
side effect suffered by cancer patients.
Company Details
Year Established:
2000
Number of Employees:
40
Company Information
Michael Atkin
Title:
Chief Executive Officer
Area of Responsibility:
Management Executive
Telephone:
(514) 288-5532
Fax:
(514) 288-9280
Email:
Click Here
Ann Kasaboski
Title:
Manager, Administration
Telephone:
(613) 562-5649
Fax:
(613) 562-5604
Email:
Click Here
Donald Olds
Title:
Chief Financial Officer
Telephone:
(514) 288-5532
Fax:
(514) 288-9280
John Gillard
Title:
EVP and Chief Scientific Officer
Telephone:
(514) 288-5532
Fax:
(514) 288-9280
Jon Durkin
Title:
VP Drug Discovery
Telephone:
(514) 288-5532
Fax:
(514) 288-9280
Catherine So
Title:
Business Development
Telephone:
(514) 288-5532
Fax:
(514) 288-9280
Email:
Click Here
Services
Research & Development
Biotechnology